Advisory Committee on the Medical Uses of Isotopes; Meeting Notice, 56243-56244 [2011-23211]

Download as PDF Federal Register / Vol. 76, No. 176 / Monday, September 12, 2011 / Notices Units 3 and 4), Docket Nos. 52–025– COL & 52–026–COL. This proceeding was triggered by August 11, 2011 motions filed by the Blue Ridge Environmental Defense League (BREDL) seeking to reopen the record and/or admit a new contention in the two above-captioned cases based on the Fukushima Task Force Report. The contested proceedings in both cases had been terminated at the Atomic Safety and Licensing Board Panel (ASLBP) level, and jurisdiction over BREDL’s filings initially lay with the Commission. By Order dated August 18, 2011, the Commission, acting through the Office of the Secretary, referred the pleadings to the ASLBP for appropriate action consistent with 10 CFR 2.309 and 2.326. The Board is comprised of the following administrative judges: Alan S. Rosenthal, Chair, Atomic Safety and Licensing Board Panel, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; Dr. Gary S. Arnold, Atomic Safety and Licensing Board Panel, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; Dr. William H. Reed, Atomic Safety and Licensing Board Panel, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001. All correspondence, documents, and other materials shall be filed in accordance with the NRC E-Filing rule, which the NRC promulgated in August 2007 (72 FR 49,139). Dated: Issued at Rockville, Maryland, this 6th day of September 2011. E. Roy Hawkens, Chief Administrative Judge, Atomic Safety and Licensing Board Panel. [FR Doc. 2011–23214 Filed 9–9–11; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [Docket Nos. 52–025–COL, 52–026–COL; 52–039–COL; 52–034–COL, 52–035–COL; ASLBP No. 11–914–02–COL–BD01] mstockstill on DSK4VPTVN1PROD with NOTICES Southern Nuclear Operating Co., PPL Bell Bend, L.L.C., Luminant Generation Company LLC; Establishment of Atomic Safety and Licensing Board Pursuant to delegation by the Commission dated December 29, 1972, published in the Federal Register, 37 FR 28,710 (1972), and the Commission’s regulations, see, e.g., 10 CFR 2.104, 2.105, 2.300, 2.309, 2.313, 2.318, and 2.321, notice is hereby given that an Atomic Safety and Licensing Board (Board) is being established to preside VerDate Mar<15>2010 16:36 Sep 09, 2011 Jkt 223001 over this proceeding, which involves the following captioned cases: Southern Nuclear Operating Co., (Vogtle Electric Generating Plant, Units 3 and 4), Docket Nos. 52–025–COL & 52– 026–COL. PPL Bell Bend, L.L.C., (Bell Bend Nuclear Power Plant), Docket No. 52– 039–COL. Luminant Generation Company LLC, (Comanche Peak Nuclear Power Plant, Units 3 and 4), Docket Nos. 52–034– COL & 52–035–COL. This proceeding was triggered by the following recent filings that were based on the Fukushima Task Force Report: (1) The Center for a Sustainable Coast, Georgia Women’s Action for New Directions, and Southern Alliance for Clean Energy filed a motion to reopen the record and admit a new contention in the above-captioned Vogtle case; (2) Gene Stilp filed a motion to reopen the record and admit a new contention in the above-captioned Bell Bend case; and (3) Public Citizen, the Sustainable Energy and Economic Development Coalition, and Lon Burnam filed a motion to reopen the record and admit a new contention in the abovecaptioned Comanche Peak case. The contested proceedings in these cases had been terminated at the Atomic Safety and Licensing Board Panel (ASLBP) level, and jurisdiction over these filings initially lay with the Commission. By order dated August 30, 2011, the Commission, acting through the Office of the Secretary, referred the pleadings to the ASLBP for appropriate action consistent with 10 CFR 2.309 and 2.326. The Board is comprised of the following administrative judges: Alan S. Rosenthal, Chair, Atomic Safety and Licensing Board Panel, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001. Dr. Gary S. Arnold, Atomic Safety and Licensing Board Panel, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001. Dr. William H. Reed, Atomic Safety and Licensing Board Panel, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001. All correspondence, documents, and other materials shall be filed in accordance with the NRC E–Filing rule, which the NRC promulgated in August 2007 (72 FR 49,139). Issued at Rockville, Maryland this 6th day of September 2011. E. Roy Hawkens, Chief Administrative Judge, Atomic Safety and Licensing Board anel. [FR Doc. 2011–23221 Filed 9–9–11; 8:45 am] BILLING CODE 7590–01–P PO 00000 Frm 00103 Fmt 4703 Sfmt 4703 56243 NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes; Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: NRC will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on September 22–23, 2011. A sample of agenda items to be discussed during the public session includes: (1) A discussion on the reporting structure and methods of ACMUI and Advisory Committee on Reactor Safeguards best practices; (2) an update on the status of a Commission paper on data collection regarding patient release; (3) a discussion on electronic signatures for documents that are required to be signed in accordance with U.S. Nuclear Regulatory Commission (NRC) regulations; (4) a discussion on strontium breakthrough with rubidium82 generators from a U.S. Food and Drug Administration perspective; (5) a discussion on strontium breakthrough with rubidium-82 generators from an NRC perspective; (6) a discussion on ACMUI’s 2008 recommended revisions to the medical event abnormal occurrence language; (7) a discussion on medical-related events; (8) a summary from the outcomes of the NRC Medical Related Rulemaking Workshops; (9) a discussion on possible changes to the permanent implant brachytherapy subcommittee report; (10) and the status of 10 CFR part 35 rulemaking. A copy of the agenda will be available at https://www.nrc.gov/reading-rm/doccollections/acmui/agenda or by emailing Ms. Sophie Holiday at the contact information below. Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material. Date and Time for Closed Session: September 22, 2011, from 8 a.m. to 12 p.m. This session will be closed so that ACMUI members can enroll for and activate new badges and undergo NRC training. Date and Time for Open Sessions: September 22, 2011, from 1:30 p.m. to 5 p.m. and September 23, 2011, from 8 a.m. to 4 p.m. Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Room T2– B3, 11545 Rockville Pike, Rockville, Maryland 20852. Public Participation: Any member of the public who wishes to participate in the meeting in person or via phone SUMMARY: E:\FR\FM\12SEN1.SGM 12SEN1 56244 Federal Register / Vol. 76, No. 176 / Monday, September 12, 2011 / Notices should contact Ms. Holiday using the information below. The meeting will also be webcast live: https:// www.nrc.gov/public-involve/publicmeetings/webcast-live.html. Contact Information: Sophie J. Holiday, e-mail: sophie.holiday@nrc.gov, telephone: (301) 415–7865. Conduct of the Meeting Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Holiday at the contact information listed above. All submittals must be received by September 16, 2011, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman. 3. The draft transcript will be available on ACMUI’s Web site (https:// www.nrc.gov/reading-rm/doccollections/acmui/tr/) on or about October 25, 2011. A meeting summary will be available on ACMUI’s Web site (https://www.nrc.gov/reading-rm/doccollections/acmui/meeting-summaries/) on or about November 4, 2011. 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Holiday of their planned attendance. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10, U.S. Code of Federal Regulations, part 7. Dated: September 6, 2011. Annette L. Vietti-Cook, Secretary of the Commission. [FR Doc. 2011–23211 Filed 9–9–11; 8:45 am] SECURITIES AND EXCHANGE COMMISSION mstockstill on DSK4VPTVN1PROD with NOTICES Sunshine Act Meeting Notice is hereby given, pursuant to the provisions of the Government in the Sunshine Act, Public Law 94–409, that the Securities and Exchange Commission will hold a Closed Meeting on Thursday, September 15, 2011 at 2 p.m. Commissioners, Counsel to the Commissioners, the Secretary to the 16:36 Sep 09, 2011 Jkt 223001 Institution and settlement of injunctive actions; Institution and settlement of administrative proceedings; Adjudicatory matters; and Other matters relating to enforcement proceedings. At times, changes in Commission priorities require alterations in the scheduling of meeting items. For further information and to ascertain what, if any, matters have been added, deleted or postponed, please contact: The Office of the Secretary at (202) 551–5400. Dated: September 8, 2011. Elizabeth M. Murphy, Secretary. lack of current and accurate information concerning the securities of Quantum Group, Inc. (The) because it has not filed any periodic reports since the period ended July 31, 2009. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Tradequest International, Inc. because it has not filed any periodic reports since the period ended September 30, 2007. The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed companies. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the abovelisted companies is suspended for the period from 9:30 a.m. EDT on September 8, 2011, through 11:59 p.m. EDT on September 21, 2011. By the Commission. Jill M. Peterson, Assistant Secretary. [FR Doc. 2011–23307 Filed 9–8–11; 11:15 am] BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION [Release No. 34–65264; File No. SR–NYSE– 2011–44] SECURITIES AND EXCHANGE COMMISSION Self-Regulatory Organizations; New York Stock Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Amending Section 501.00 of the Listed Company Manual To Expand the Waiver Provision To Apply to Foreign Issuers [File No. 500–1] September 6, 2011. [FR Doc. 2011–23319 Filed 9–8–11; 4:15 pm] BILLING CODE 8011–01–P Dialpoint Communications Corp., Pacel Corp., Quantum Group, Inc. (The), and Tradequest International, Inc.; Order of Suspension of Trading September 8, 2011. BILLING CODE 7590–01–P VerDate Mar<15>2010 Commission, and recording secretaries will attend the Closed Meeting. Certain staff members who have an interest in the matters also may be present. The General Counsel of the Commission, or his designee, has certified that, in his opinion, one or more of the exemptions set forth in 5 U.S.C. 552b(c)(3), (5), (7), 9(B) and (10) and 17 CFR 200.402(a)(3), (5), (7), 9(ii) and (10), permit consideration of the scheduled matters at the Closed Meeting. Commissioner Paredes, as duty officer, voted to consider the items listed for the Closed Meeting in a closed session. The subject matter of the Closed Meeting scheduled for Thursday, September 15, 2011 will be: It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Dialpoint Communications Corp. because it has not filed any periodic reports since the period ended September 30, 2008. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Pacel Corp. because it has not filed any periodic reports since the period ended September 30, 2006. It appears to the Securities and Exchange Commission that there is a PO 00000 Frm 00104 Fmt 4703 Sfmt 4703 Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (‘‘Act’’),1 notice is hereby given that on August 22, 2011, New York Stock Exchange LLC (‘‘NYSE’’) filed with the Securities and Exchange Commission (‘‘Commission’’) the proposed rule change described in Items I and II below, which items have been prepared primarily by NYSE.2 NYSE filed the proposed rule change pursuant to Section 19(b)(3)(A)(iii) and Rule 19b– 4(f)(6) thereunder so that the proposed rule change was effective upon filing with the Commission.3 The Commission is publishing this notice to solicit 1 15 U.S.C. 78s(b)(1). text of the proposed rule change is attached as Exhibit 5 to NYSE’s filing, which is available at https://www.nyse.com. 3 15 U.S.C. 78s(b)(3)(A)(iii) and 17 CFR 240.19b– 4(f)(6). 2 The E:\FR\FM\12SEN1.SGM 12SEN1

Agencies

[Federal Register Volume 76, Number 176 (Monday, September 12, 2011)]
[Notices]
[Pages 56243-56244]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-23211]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes; Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: NRC will convene a meeting of the Advisory Committee on the 
Medical Uses of Isotopes (ACMUI) on September 22-23, 2011. A sample of 
agenda items to be discussed during the public session includes: (1) A 
discussion on the reporting structure and methods of ACMUI and Advisory 
Committee on Reactor Safeguards best practices; (2) an update on the 
status of a Commission paper on data collection regarding patient 
release; (3) a discussion on electronic signatures for documents that 
are required to be signed in accordance with U.S. Nuclear Regulatory 
Commission (NRC) regulations; (4) a discussion on strontium 
breakthrough with rubidium-82 generators from a U.S. Food and Drug 
Administration perspective; (5) a discussion on strontium breakthrough 
with rubidium-82 generators from an NRC perspective; (6) a discussion 
on ACMUI's 2008 recommended revisions to the medical event abnormal 
occurrence language; (7) a discussion on medical-related events; (8) a 
summary from the outcomes of the NRC Medical Related Rulemaking 
Workshops; (9) a discussion on possible changes to the permanent 
implant brachytherapy subcommittee report; (10) and the status of 10 
CFR part 35 rulemaking. A copy of the agenda will be available at 
https://www.nrc.gov/reading-rm/doc-collections/acmui/agenda or by e-
mailing Ms. Sophie Holiday at the contact information below.
    Purpose: Discuss issues related to 10 CFR part 35 Medical Use of 
Byproduct Material.
    Date and Time for Closed Session: September 22, 2011, from 8 a.m. 
to 12 p.m. This session will be closed so that ACMUI members can enroll 
for and activate new badges and undergo NRC training.
    Date and Time for Open Sessions: September 22, 2011, from 1:30 p.m. 
to 5 p.m. and September 23, 2011, from 8 a.m. to 4 p.m.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2-B3, 11545 Rockville Pike, 
Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting in person or via phone

[[Page 56244]]

should contact Ms. Holiday using the information below. The meeting 
will also be webcast live: https://www.nrc.gov/public-involve/public-meetings/webcast-live.html.
    Contact Information: Sophie J. Holiday, e-mail: 
sophie.holiday@nrc.gov, telephone: (301) 415-7865.

Conduct of the Meeting

    Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Holiday at the contact information listed above. 
All submittals must be received by September 16, 2011, and must pertain 
to the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript will be available on ACMUI's Web site 
(https://www.nrc.gov/reading-rm/doc-collections/acmui/tr/) on or about 
October 25, 2011. A meeting summary will be available on ACMUI's Web 
site (https://www.nrc.gov/reading-rm/doc-collections/acmui/meeting-summaries/) on or about November 4, 2011.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Holiday of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, part 7.

    Dated: September 6, 2011.
Annette L. Vietti-Cook,
Secretary of the Commission.
[FR Doc. 2011-23211 Filed 9-9-11; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.